Table 1.
Tumor type | Method | Citation | |
---|---|---|---|
% 8q GAINa | |||
38 | Primary + LN met | SNP, qPCR | Liu et al. (108) |
27 | Primary + LN met | CGH | Lapointe et al. (53) |
72 | CRPC | CGH | Nupponen et al. (54) |
% 8q24 GAINa | |||
9 | Primary (LG) | FISH | Gurel et al. (50, 55) |
28 | Primary (HG) | FISH | Gurel et al. (50, 55) |
% Myc GAINa | |||
77 | CRPC | FISH | Nupponen et al. (54) |
21 | Primary | DNA array | Edwards et al. (56) |
63 | CRPC | DNA array | Edwards et al. (56) |
Myc IHC SCORE | |||
2.6 | Normal | IHC | Gurel et al. (50, 55) |
8.6 | LG-PIN | IHC | Gurel et al. (50, 55) |
25.8 | HG-PIN | IHC | Gurel et al. (50, 55) |
27.1 | Primary | IHC | Gurel et al. (50, 55) |
14.9 | Met | IHC | Gurel et al. (50, 55) |
a Percentage of tumors displaying the change.
LN, lymph node; CRPC, castration-resistant PCa; LG, low grade; HG, high grade; Met, metastasis.